DRD3 variation associates with early-onset heroin dependence, but not specific personality traits

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 51, Issue , 2014, Pages 1-8

  Kuo, Shin Chang ^a,b   Yeh, Yi Wei ^a,b   Chen, Chun Yen ^a,b   Huang, Chang Chih ^a,c   Chang, Hsin An ^b   Yen, Che Hung ^a,b   Ho, Pei Shen ^b   Liang, Chih Sung ^a,b   Chou, Han Wei ^b   Lu, Ru Band ^d   Huang, San Yuan ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

DRD3 gene; Heroin dependence; Personality trait; Polymorphisms

Indexed keywords

DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRD3 GENE; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERSONALITY; SUBSTANCE ABUSE; GENETICS; GENOTYPE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEROIN DEPENDENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERSONALITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D3;

EID: 84892534730     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.12.018     Document Type: Article

References (75)

1. Agrawal A., Wetherill L., Bucholz K.K., Kramer J., Kuperman S., Lynskey M.T., et al. Genetic influences on craving for alcohol. Addict Behav 2013, 38:1501-1508.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorder 1994, American Psychiatric Association, Washington DC. 4th ed.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Basiaux P., le Bon O., Dramaix M., Massat I., Souery D., Mendlewicz J., et al. Temperament and Character Inventory (TCI) personality profile and sub-typing in alcoholic patients: a controlled study. Alcohol Alcohol 2001, 36:584-587.
5. Behrendt S., Wittchen H.U., Hofler M., Lieb R., Beesdo K. Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation?. Drug Alcohol Depend 2009, 99:68-78.
6. Beninger R.J., Banasikowski T.J. Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor. Neurotox Res 2008, 14:57-70.
7. Bloch P.J., Nall A.H., Weller A.E., Ferraro T.N., Berrettini W.H., Kampman K.M., et al. Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence. Psychiatr Genet 2009, 19:275-276.
8. Cami J., Farre M. Drug addiction. N Engl J Med 2003, 349:975-986.
9. Chen W.J., Chen H.M., Chen C.C., Yu W.Y., Cheng A.T. Cloninger's Tridimensional Personality Questionnaire: psychometric properties and construct validity in Taiwanese adults. Compr Psychiatry 2002, 43:158-166.
10. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993, 50:975-990.
11. Comings D.E., Gonzalez N., Wu S., Saucier G., Johnson P., Verde R., et al. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol Psychiatry 1999, 4:484-487.
12. Crettol S., Besson J., Croquette-Krokar M., Hammig R., Gothuey I., Monnat M., et al. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1722-1727.
13. Duaux E., Gorwood P., Griffon N., Bourdel M.C., Sautel F., Sokoloff P., et al. Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry 1998, 3:333-336.
14. Ebstein R.P., Segman R., Benjamin J., Osher Y., Nemanov L., Belmaker R.H. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet 1997, 74:65-72.
15. El Rawas R., Thiriet N., Lardeux V., Jaber M., Solinas M. Environmental enrichment decreases the rewarding but not the activating effects of heroin. Psychopharmacology (Berl) 2009, 203:561-570.
16. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978, 35:837-844.
17. Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009, 41:1149-1160.
18. Freimer M., Kranzler H., Satel S., Lacobelle J., Skipsey K., Charney D., et al. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict Biol 1996, 1:281-287.
19. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
20. Griesler P.C., Hu M.C., Schaffran C., Kandel D.B. Comorbidity of psychiatric disorders and nicotine dependence among adolescents: findings from a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 2008, 47:1340-1350.
21. Gunnarsdottir E.D., Pingitore R.A., Spring B.J., Konopka L.M., Crayton J.W., Milo T., et al. Individual differences among cocaine users. Addict Behav 2000, 25:641-652.
22. Hall W., Doran C., Degenhardt L., Shepard D. Illicit opiate abuse 2006.
23. Heidbreder C.A., Gardner E.L., Xi Z.X., Thanos P.K., Mugnaini M., Hagan J.J., et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 2005, 49:77-105.
24. Hellstrand M., Danielsen E.A., Steen V.M., Ekman A., Eriksson E., Nilsson C.L. The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 2004, 41:867-871.
25. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D.A. 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001, 58:503-508.
26. Huang S.Y., Lin W.W., Ko H.C., Lee J.F., Wang T.J., Chou Y.H., et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 2004, 28:374-384.
27. Huang W., Payne T.J., Ma J.Z., Li M.D. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1109-1115.
28. Huang H.Y., Lee I.H., Chen K.C., Yeh T.L., Chen P.S., Yang Y.K., et al. Association of novelty seeking scores and striatal dopamine D(2)/D(3) receptor availability of healthy volunteers: single photon emission computed tomography with (1)(2)(3)i-iodobenzamide. J Formos Med Assoc 2010, 109:736-739.
29. Huang S.Y., Chen H.K., Ma K.H., Shy M.J., Chen J.H., Lin W.C., et al. Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res 2010, 116:68-74.
30. Hung C.C., Chiou M.H., Huang B.H., Hsieh Y.W., Hsieh T.J., Huang C.L., et al. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics 2011, 12:1525-1533.
31. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
32. Jeanneteau F., Funalot B., Jankovic J., Deng H., Lagarde J.P., Lucotte G., et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A 2006, 103:10753-10758.
33. Jonsson E.G., Burgert E., Crocq M.A., Gustavsson J.P., Forslund K., Mattila-Evenden M., et al. Association study between dopamine D3 receptor gene variant and personality traits. Am J Med Genet B Neuropsychiatr Genet 2003, 117B:61-65.
34. Joyce P.R., Rogers G.R., Miller A.L., Mulder R.T., Luty S.E., Kennedy M.A. Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry Res 2003, 119:1-10.
35. Karkowski L.M., Prescott C.A., Kendler K.S. Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am J Med Genet 2000, 96:665-670.
36. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003, 160:687-695.
37. Ko C.H., Yen J.Y., Chen C.C., Chen S.H., Wu K., Yen C.F. Tridimensional personality of adolescents with internet addiction and substance use experience. Can J Psychiatry 2006, 51:887-894.
38. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997, 9:482-497.
39. Kotler M., Cohen H., Kremer I., Mel H., Horowitz R., Ohel N., et al. No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction. Mol Psychiatry 1999, 4:313-314.
40. Kumar D., Chakraborty J., Das S. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:225-230.
41. Le Coniat M., Sokoloff P., Hillion J., Martres M.P., Giros B., Pilon C., et al. Chromosomal localization of the human D3 dopamine receptor gene. Hum Genet 1991, 87:618-620.
42. Le Foll B., Goldberg S.R., Sokoloff P. The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Neuropharmacology 2005, 49:525-541.
43. Li T., Liu X., Zhao J., Hu X., Ball D.M., Loh el W., et al. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am J Med Genet 2002, 114:329-335.
44. Li T., Yu S., Du J., Chen H., Jiang H., Xu K., et al. Role of novelty seeking personality traits as mediator of the association between COMT and onset age of drug use in Chinese heroin dependent patients. PLoS One 2011, 6:e22923.
45. Lim S., Ha J., Choi S.W., Kang S.G., Shin Y.C. Association study on pathological gambling and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in a Korean population. J Gambl Stud 2012, 28:481-491.
46. Limosin F., Romo L., Batel P., Ades J., Boni C., Gorwood P. Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men. Eur Psychiatry 2005, 20:304-306.
47. Merikangas K.R., Stevens D.E., Fenton B., Stolar M., O'Malley S., Woods S.W., et al. Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med 1998, 28:773-788.
48. Messas G., Meira-Lima I., Turchi M., Franco O., Guindalini C., Castelo A., et al. Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. Psychiatr Genet 2005, 15:171-174.
49. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003, 116B:103-125.
50. Novak G., LeBlanc M., Zai C., Shaikh S., Renou J., DeLuca V., et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 2010, 74:291-298.
51. Nunokawa A., Watanabe Y., Kaneko N., Sugai T., Yazaki S., Arinami T., et al. The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: case-control studies and an updated meta-analysis. Schizophr Res 2010, 116:61-67.
52. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev 2006, 30:215-238.
53. Prisciandaro J.J., Korte J.E., McRae-Clark A.L., Brady K.T. Associations between behavioral disinhibition and cocaine use history in individuals with cocaine dependence. Addict Behav 2012, 37:1185-1188.
54. Rodriguez-Llera M.C., Domingo-Salvany A., Brugal M.T., Silva T.C., Sanchez-Niubo A., Torrens M., et al. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend 2006, 84:48-55.
55. Sartor C.E., Agrawal A., Lynskey M.T., Bucholz K.K., Madden P.A., Heath A.C. Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women. Drug Alcohol Depend 2009, 102:49-55.
56. Schosser A., Fuchs K., Scharl T., Schloegelhofer M., Kindler J., Mossaheb N., et al. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry 2010, 11:417-424.
57. Smits B.M., D'Souza U.M., Berezikov E., Cuppen E., Sluyter F. Identifying polymorphisms in the Rattus norvegicus D3 dopamine receptor gene and regulatory region. Genes Brain Behav 2004, 3:138-148.
58. Staner L., Hilger C., Hentges F., Monreal J., Hoffmann A., Couturier M., et al. Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients: a preliminary report. Am J Med Genet 1998, 81:192-194.
59. Talkowski M.E., Mansour H., Chowdari K.V., Wood J., Butler A., Varma P.G., et al. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biol Psychiatry 2006, 60:570-577.
60. Thome J., Weijers H.G., Wiesbeck G.A., Sian J., Nara K., Boning J., et al. Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatr Genet 1999, 9:17-21.
61. Tikkanen R., Holi M., Lindberg N., Virkkunen M. Tridimensional Personality Questionnaire data on alcoholic violent offenders: specific connections to severe impulsive cluster B personality disorders and violent criminality. BMC Psychiatry 2007, 7:36.
62. Tsuang M.T., Lyons M.J., Eisen S.A., Goldberg J., True W., Lin N., et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 1996, 67:473-477.
63. Urata T., Takahashi N., Hakamata Y., Iijima Y., Kuwahara N., Ozaki N., et al. Gene-gene interaction analysis of personality traits in a Japanese population using an electrochemical DNA array chip analysis. Neurosci Lett 2007, 414:209-212.
64. Vandenbergh D.J., O'Connor R.J., Grant M.D., Jefferson A.L., Vogler G.P., Strasser A.A., et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol 2007, 12:106-116.
65. Wang T.Y., Lee S.Y., Chen S.L., Chang Y.H., Chen S.H., Chu C.H., et al. The ADH1B and DRD2 gene polymorphism may modify the protective effect of the ALDH2 gene against heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry 2013, 43:134-139.
66. Wiesbeck G.A., Dursteler-MacFarland K.M., Wurst F.M., Walter M., Petitjean S., Muller S., et al. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Addict Biol 2006, 11:72-75.
67. Wills T.A., Vaccaro D., McNamara G. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 1994, 6:1-20.
68. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
69. Yang H.C., Lin C.H., Hsu C.L., Hung S.I., Wu J.Y., Pan W.H., et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci 2006, 13:489-498.
70. Yang M., Kavi V., Wang W., Wu Z., Hao W. The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:282-289.
71. Yasseen B., Kennedy J.L., Zawertailo L.A., Busto U.E. Comorbidity between bipolar disorder and alcohol use disorder: association of dopamine and serotonin gene polymorphisms. Psychiatry Res 2010, 176:30-33.
72. Yeh Y.W., Lu R.B., Tao P.L., Shih M.C., Lin W.W., Huang S.Y. Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav 2010, 9:638-647.
73. Yue K., Ma B., Ru Q., Chen L., Gan Y., Wang D., et al. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats. Pharmacol Biochem Behav 2012, 102:1-5.
74. Zhang F., Fan H., Xu Y., Zhang K., Huang X., Zhu Y., et al. Converging evidence implicates the dopamine D3 receptor gene in vulnerability to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:613-619.
75. Zhang G., Liu H., Xue H., Shan D., Yang Y.C., Duan S., et al. Analysis of quality of life and its influencing factors of heroin dependent patients with methadone maintenance therapy in Dehong prefecture, Yunnan province. Zhonghua Yu Fang Yi Xue Za Zhi 2011, 45:985-989.